Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity-Reference-Cited by-同舟云学术

Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity

Published:2021-10-08 Issue:1 Volume:22 Page:67-77
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Pondugula Satyanarayana R.,Harshan Aisha,Ramesh Sindhu,Govindarajulu Manoj,Almaghrabi Mohammed,Majrashi Mohammed,Abbott Kodye L.,Nadar Rishi,Alturki Mansour,Salamat Julia M.,Smith Forrest,Majeed Muhammed,Nagabhushanam Kalyanam,Moore Timothy,Ren Jun,Dhanasekaran Muralikrishnan

Funder

sabinsa corporation

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s12012-021-09701-x.pdf

Reference45 articles.

1. Dhesi, S., Chu, M. P., Blevins, G., Paterson, I., Larratt, L., Oudit, G. Y., & Kim, D. H. (2013). Cyclophosphamide-induced cardiomyopathy: A case report, review, and recommendations for management. Journal of Investigative Medicine High Impact Case Reports, 1(1), 2324709613480346. https://doi.org/10.1177/2324709613480346

2. Swain, S. M. (1999). Doxorubicin-induced cardiomyopathy. New England Journal of Medicine, 340(8), 654 (author reply 655)

3. Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D. A., & St Clair, D. K. (2007). Collateral damage in cancer chemotherapy: Oxidative stress in nontargeted tissues. Molecular Interventions, 7(3), 147–156. https://doi.org/10.1124/mi.7.3.6